aluates Reports

$ 0.0

Automative

Enbrel - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-16W10635

Global and United States Enbrel Market Report Forecast 2022 2028

BUY CHAPTERS

Enbrel - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16W10635

Report

October 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Pfizer Inc

3SBio Inc

Celgen Biopharma

Enbrel - Market Size

The global market for Enbrel was estimated to be worth US$ 8764 million in 2023 and is forecast to a readjusted size of US$ 10530 million by 2030 with a CAGR of 2.6% during the forecast period 2024-2030

Enbrel - Market

Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor.

The Enbrel market is primarily driven by the demand for effective treatment options for autoimmune diseases. Enbrel (etanercept) is a medication used to treat conditions like rheumatoid arthritis, psoriasis, and ankylosing spondylitis. The increasing prevalence of autoimmune disorders and the growing recognition of their impact on patient quality of life contribute to market growth. Moreover, advancements in biologic therapies and the demonstrated efficacy of Enbrel in reducing disease symptoms further propel adoption. However, challenges include managing the high cost of biologic treatments and addressing potential side effects. Navigating patient access issues, optimizing treatment protocols, and ensuring long-term safety are ongoing concerns. The market's success relies on continuous research in autoimmune disease management, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of Enbrel treatment while addressing the evolving challenges associated with autoimmune disease treatment access and affordability.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enbrel, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enbrel by region & country, by Type, and by Application.

The Enbrel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enbrel.

Market Segmentation

Scope of Enbrel - Market Report

Report Metric	Details
Report Name	Enbrel - Market
Forecasted market size in 2030	US$ 10530 million
CAGR	2.6%
Forecasted years	2024 - 2030
Segment by Type:	Brands Drugs Biosimilar Drugs
Segment by Application	Rheumatoid Arthritis Juvenile Idiopathic Arthritis Psoriatic Arthritis Ankylosing Spondylitis Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Pfizer, 3SBIO, Celgen Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Enbrel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Enbrel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Enbrel in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Enbrel - Market size in 2030?

Ans: The Enbrel - Market size in 2030 will be US$ 10530 million.

Who are the main players in the Enbrel - Market report?

Ans: The main players in the Enbrel - Market are Amgen, Pfizer, 3SBIO, Celgen Biopharma

What are the Application segmentation covered in the Enbrel - Market report?

Ans: The Applications covered in the Enbrel - Market report are Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Other

What are the Type segmentation covered in the Enbrel - Market report?

Ans: The Types covered in the Enbrel - Market report are Brands Drugs, Biosimilar Drugs

1 Market Overview

1.1 Enbrel Product Introduction

1.2 Global Enbrel Market Size Forecast

1.2.1 Global Enbrel Sales Value (2019-2030)

1.2.2 Global Enbrel Sales Volume (2019-2030)

1.2.3 Global Enbrel Sales Price (2019-2030)

1.3 Enbrel Market Trends & Drivers

1.3.1 Enbrel Industry Trends

1.3.2 Enbrel Market Drivers & Opportunity

1.3.3 Enbrel Market Challenges

1.3.4 Enbrel Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Enbrel Players Revenue Ranking (2023)

2.2 Global Enbrel Revenue by Company (2019-2024)

2.3 Global Enbrel Players Sales Volume Ranking (2023)

2.4 Global Enbrel Sales Volume by Company Players (2019-2024)

2.5 Global Enbrel Average Price by Company (2019-2024)

2.6 Key Manufacturers Enbrel Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Enbrel Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Enbrel

2.9 Enbrel Market Competitive Analysis

2.9.1 Enbrel Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Enbrel Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enbrel as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Brands Drugs

3.1.2 Biosimilar Drugs

3.2 Global Enbrel Sales Value by Type

3.2.1 Global Enbrel Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Enbrel Sales Value, by Type (2019-2030)

3.2.3 Global Enbrel Sales Value, by Type (%) (2019-2030)

3.3 Global Enbrel Sales Volume by Type

3.3.1 Global Enbrel Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Enbrel Sales Volume, by Type (2019-2030)

3.3.3 Global Enbrel Sales Volume, by Type (%) (2019-2030)

3.4 Global Enbrel Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Rheumatoid Arthritis

4.1.2 Juvenile Idiopathic Arthritis

4.1.3 Psoriatic Arthritis

4.1.4 Ankylosing Spondylitis

4.1.5 Other

4.2 Global Enbrel Sales Value by Application

4.2.1 Global Enbrel Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Enbrel Sales Value, by Application (2019-2030)

4.2.3 Global Enbrel Sales Value, by Application (%) (2019-2030)

4.3 Global Enbrel Sales Volume by Application

4.3.1 Global Enbrel Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Enbrel Sales Volume, by Application (2019-2030)

4.3.3 Global Enbrel Sales Volume, by Application (%) (2019-2030)

4.4 Global Enbrel Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Enbrel Sales Value by Region

5.1.1 Global Enbrel Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Enbrel Sales Value by Region (2019-2024)

5.1.3 Global Enbrel Sales Value by Region (2025-2030)

5.1.4 Global Enbrel Sales Value by Region (%), (2019-2030)

5.2 Global Enbrel Sales Volume by Region

5.2.1 Global Enbrel Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Enbrel Sales Volume by Region (2019-2024)

5.2.3 Global Enbrel Sales Volume by Region (2025-2030)

5.2.4 Global Enbrel Sales Volume by Region (%), (2019-2030)

5.3 Global Enbrel Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Enbrel Sales Value, 2019-2030

5.4.2 North America Enbrel Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Enbrel Sales Value, 2019-2030

5.5.2 Europe Enbrel Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Enbrel Sales Value, 2019-2030

5.6.2 Asia Pacific Enbrel Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Enbrel Sales Value, 2019-2030

5.7.2 South America Enbrel Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Enbrel Sales Value, 2019-2030

5.8.2 Middle East & Africa Enbrel Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Enbrel Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Enbrel Sales Value

6.2.1 Key Countries/Regions Enbrel Sales Value, 2019-2030

6.2.2 Key Countries/Regions Enbrel Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Enbrel Sales Value, 2019-2030

6.3.2 United States Enbrel Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Enbrel Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Enbrel Sales Value, 2019-2030

6.4.2 Europe Enbrel Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Enbrel Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Enbrel Sales Value, 2019-2030

6.5.2 China Enbrel Sales Value by Type (%), 2023 VS 2030

6.5.3 China Enbrel Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Enbrel Sales Value, 2019-2030

6.6.2 Japan Enbrel Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Enbrel Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Enbrel Sales Value, 2019-2030

6.7.2 South Korea Enbrel Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Enbrel Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Enbrel Sales Value, 2019-2030

6.8.2 Southeast Asia Enbrel Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Enbrel Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Enbrel Sales Value, 2019-2030

6.9.2 India Enbrel Sales Value by Type (%), 2023 VS 2030

6.9.3 India Enbrel Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Amgen

7.1.1 Amgen Company Information

7.1.2 Amgen Introduction and Business Overview

7.1.3 Amgen Enbrel Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Amgen Enbrel Product Offerings

7.1.5 Amgen Recent Development

7.2 Pfizer

7.2.1 Pfizer Company Information

7.2.2 Pfizer Introduction and Business Overview

7.2.3 Pfizer Enbrel Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer Enbrel Product Offerings

7.2.5 Pfizer Recent Development

7.3 3SBIO

7.3.1 3SBIO Company Information

7.3.2 3SBIO Introduction and Business Overview

7.3.3 3SBIO Enbrel Sales, Revenue and Gross Margin (2019-2024)

7.3.4 3SBIO Enbrel Product Offerings

7.3.5 3SBIO Recent Development

7.4 Celgen Biopharma

7.4.1 Celgen Biopharma Company Information

7.4.2 Celgen Biopharma Introduction and Business Overview

7.4.3 Celgen Biopharma Enbrel Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Celgen Biopharma Enbrel Product Offerings

7.4.5 Celgen Biopharma Recent Development

8 Industry Chain Analysis

8.1 Enbrel Industrial Chain

8.2 Enbrel Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Enbrel Sales Model

8.5.2 Sales Channel

8.5.3 Enbrel Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Pfizer Inc

3SBio Inc

Celgen Biopharma

List of Tables

Table 1. Enbrel Market Trends

Table 2. Enbrel Market Drivers & Opportunity

Table 3. Enbrel Market Challenges

Table 4. Enbrel Market Restraints

Table 5. Global Enbrel Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Enbrel Revenue Market Share by Company (2019-2024)

Table 7. Global Enbrel Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Enbrel Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Enbrel Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Enbrel Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Enbrel Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Enbrel

Table 13. Global Enbrel Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enbrel as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Enbrel Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Enbrel Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Enbrel Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Enbrel Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Enbrel Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Enbrel Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Enbrel Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Enbrel Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Enbrel Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Enbrel Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Enbrel Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Enbrel Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Enbrel Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Enbrel Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Enbrel Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Enbrel Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Enbrel Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Enbrel Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Enbrel Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Enbrel Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Enbrel Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Enbrel Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Enbrel Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Enbrel Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Enbrel Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Enbrel Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Enbrel Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Enbrel Sales Value by Region (2019-2024) & (%)

Table 44. Global Enbrel Sales Value by Region (2025-2030) & (%)

Table 45. Global Enbrel Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Enbrel Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Enbrel Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Enbrel Sales Volume by Region (2019-2024) & (%)

Table 49. Global Enbrel Sales Volume by Region (2025-2030) & (%)

Table 50. Global Enbrel Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Enbrel Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Enbrel Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Enbrel Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Enbrel Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Enbrel Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Enbrel Sales Volume, (2025-2030) & (K Units)

Table 57. Amgen Company Information

Table 58. Amgen Introduction and Business Overview

Table 59. Amgen Enbrel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Amgen Enbrel Product Offerings

Table 61. Amgen Recent Development

Table 62. Pfizer Company Information

Table 63. Pfizer Introduction and Business Overview

Table 64. Pfizer Enbrel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Pfizer Enbrel Product Offerings

Table 66. Pfizer Recent Development

Table 67. 3SBIO Company Information

Table 68. 3SBIO Introduction and Business Overview

Table 69. 3SBIO Enbrel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. 3SBIO Enbrel Product Offerings

Table 71. 3SBIO Recent Development

Table 72. Celgen Biopharma Company Information

Table 73. Celgen Biopharma Introduction and Business Overview

Table 74. Celgen Biopharma Enbrel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Celgen Biopharma Enbrel Product Offerings

Table 76. Celgen Biopharma Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Enbrel Downstream Customers

Table 80. Enbrel Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Enbrel Product Picture

Figure 2. Global Enbrel Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Enbrel Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Enbrel Sales Volume (2019-2030) & (K Units)

Figure 5. Global Enbrel Sales Price (2019-2030) & (US$/Unit)

Figure 6. Enbrel Report Years Considered

Figure 7. Global Enbrel Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Enbrel Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Enbrel Revenue in 2023

Figure 10. Enbrel Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Brands Drugs Picture

Figure 12. Biosimilar Drugs Picture

Figure 13. Global Enbrel Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Enbrel Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Enbrel Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Enbrel Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Enbrel Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Rheumatoid Arthritis

Figure 19. Product Picture of Juvenile Idiopathic Arthritis

Figure 20. Product Picture of Psoriatic Arthritis

Figure 21. Product Picture of Ankylosing Spondylitis

Figure 22. Product Picture of Other

Figure 23. Global Enbrel Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Enbrel Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Enbrel Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Enbrel Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Enbrel Price by Application (2019-2030) & (US$/Unit)

Figure 28. North America Enbrel Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Enbrel Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Enbrel Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Enbrel Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Enbrel Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Enbrel Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Enbrel Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Enbrel Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Enbrel Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Enbrel Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Enbrel Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Enbrel Sales Volume (%), (2019-2030)

Figure 40. United States Enbrel Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Enbrel Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Enbrel Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Enbrel Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Enbrel Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Enbrel Sales Value by Application (%), 2023 VS 2030

Figure 46. China Enbrel Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Enbrel Sales Value by Type (%), 2023 VS 2030

Figure 48. China Enbrel Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Enbrel Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Enbrel Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Enbrel Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Enbrel Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Enbrel Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Enbrel Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Enbrel Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Enbrel Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Enbrel Sales Value by Application (%), 2023 VS 2030

Figure 58. India Enbrel Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Enbrel Sales Value by Type (%), 2023 VS 2030

Figure 60. India Enbrel Sales Value by Application (%), 2023 VS 2030

Figure 61. Enbrel Industrial Chain

Figure 62. Enbrel Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions